Spanish Oncology Genito-urinary Group
Clinical trials sponsored by Spanish Oncology Genito-urinary Group, explained in plain language.
-
Immunotherapy combo shows promise in delaying bladder cancer progression
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) could help delay cancer growth in people with advanced bladder cancer that had not worsened after initial chemotherapy. The trial included 25 adults with unresectable or metastatic uroth…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
Real-World data shows Tivozanib's promise for kidney cancer patients
Disease control CompletedThis study reviewed medical records of 200 adults with advanced clear cell kidney cancer who received tivozanib as their first treatment. Researchers measured how long patients lived without their cancer getting worse. The goal was to see how well this drug works in everyday medi…
Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 14, 2026 12:03 UTC